NO973312D0 - Racemiseringsprosess for fremstilling av Levobupivacaine og beslektede piperidinkarboksanilid-bedövelsesmidler - Google Patents

Racemiseringsprosess for fremstilling av Levobupivacaine og beslektede piperidinkarboksanilid-bedövelsesmidler

Info

Publication number
NO973312D0
NO973312D0 NO973312A NO973312A NO973312D0 NO 973312 D0 NO973312 D0 NO 973312D0 NO 973312 A NO973312 A NO 973312A NO 973312 A NO973312 A NO 973312A NO 973312 D0 NO973312 D0 NO 973312D0
Authority
NO
Norway
Prior art keywords
levobupivacaine
anesthetics
preparation
carboxanilide
racemization process
Prior art date
Application number
NO973312A
Other languages
English (en)
Other versions
NO308843B1 (no
NO973312L (no
Inventor
Ulrich Conrad Dyer
Marianne Langston
Martin Woods
Original Assignee
Chiroscience Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiroscience Ltd filed Critical Chiroscience Ltd
Publication of NO973312D0 publication Critical patent/NO973312D0/no
Publication of NO973312L publication Critical patent/NO973312L/no
Publication of NO308843B1 publication Critical patent/NO308843B1/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Rolling Contact Bearings (AREA)
  • Optical Head (AREA)
  • Beans For Foods Or Fodder (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO973312A 1995-01-18 1997-07-17 Racemiseringsprosess for fremstilling av levobupivakain og beslektede piperidinkarboksanilid-bedøvelsesmidler NO308843B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9501071.6A GB9501071D0 (en) 1995-01-18 1995-01-18 Racemisation
PCT/GB1996/000067 WO1996022281A1 (en) 1995-01-18 1996-01-12 Racemisation process for use in the manufacture of levobupivacaine and related piperidinecarboxanilide anaesthetic agents

Publications (3)

Publication Number Publication Date
NO973312D0 true NO973312D0 (no) 1997-07-17
NO973312L NO973312L (no) 1997-07-17
NO308843B1 NO308843B1 (no) 2000-11-06

Family

ID=10768271

Family Applications (1)

Application Number Title Priority Date Filing Date
NO973312A NO308843B1 (no) 1995-01-18 1997-07-17 Racemiseringsprosess for fremstilling av levobupivakain og beslektede piperidinkarboksanilid-bedøvelsesmidler

Country Status (20)

Country Link
EP (1) EP0804417B1 (no)
JP (1) JP4015696B2 (no)
KR (1) KR100404390B1 (no)
CN (1) CN1172912C (no)
AT (1) ATE242214T1 (no)
AU (1) AU701221B2 (no)
BR (1) BR9606821A (no)
CA (1) CA2208522C (no)
DE (1) DE69628540T2 (no)
DK (1) DK0804417T3 (no)
ES (1) ES2201166T3 (no)
FI (1) FI117437B (no)
GB (1) GB9501071D0 (no)
HU (1) HU227426B1 (no)
MX (1) MX9705428A (no)
NO (1) NO308843B1 (no)
PL (1) PL184091B1 (no)
PT (1) PT804417E (no)
WO (1) WO1996022281A1 (no)
ZA (1) ZA96403B (no)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0002246A (pt) 2000-04-06 2003-04-15 Cristalia Prod Quimicos Farm Processo de obtenção dos enantiÈmeros da bupivacaìna racêmica, processo de obtenção de composições farmacêuticas a base de levobupivacaìna: composições farmacêuticas a base de levobupivacaìna formuladas nas formas básicas ou sais farmaceuticamente aceitáveis e utilização das composições farmacêuticas a base de levobupivacaìna formuladas nas formas básicas ou sais farmaceuticamente aceitáveis
US20040001889A1 (en) 2002-06-25 2004-01-01 Guohua Chen Short duration depot formulations
EP2959893A1 (en) 2002-12-13 2015-12-30 DURECT Corporation Oral drug delivery system comprising high viscosity liquid carrier materials
PL1809329T3 (pl) 2004-09-17 2012-08-31 Durect Corp Kompozycja znieczulająca zawierająca saib o przedłużonym uwalnianiu do stosowania miejscowego
US20070027105A1 (en) 2005-07-26 2007-02-01 Alza Corporation Peroxide removal from drug delivery vehicle
US8337883B2 (en) 2006-11-03 2012-12-25 Durect Corporation Transdermal delivery systems
WO2009088414A2 (en) 2007-12-06 2009-07-16 Durect Corporation Oral pharmaceutical dosage forms
US20100260844A1 (en) 2008-11-03 2010-10-14 Scicinski Jan J Oral pharmaceutical dosage forms
CN102093284B (zh) * 2010-12-29 2013-05-08 宜昌人福药业有限责任公司 富集哌啶-2-甲酰苯胺类旋光化合物的方法
CA2905131A1 (en) 2013-03-15 2014-09-18 Durect Corporation Compositions with a rheological modifier to reduce dissolution variability
CN106187864B (zh) * 2016-07-11 2018-11-23 江苏天和制药有限公司 一种由盐酸布比卡因制备高纯度布比卡因碱的方法
KR20220140711A (ko) 2020-01-13 2022-10-18 듀렉트 코퍼레이션 불순물이 감소된 지속 방출 약물 전달 시스템 및 관련 방법
WO2023158722A2 (en) * 2022-02-16 2023-08-24 Teva Pharmaceuticals International Gmbh Processes for preparation of avacopan and intermediates thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2301498A1 (fr) * 1975-02-20 1976-09-17 Maggioni & C Spa Methode pour la racemisation d'une lysine optiquement active

Also Published As

Publication number Publication date
ZA96403B (en) 1997-01-20
AU701221B2 (en) 1999-01-21
ES2201166T3 (es) 2004-03-16
AU4394896A (en) 1996-08-07
JPH11501905A (ja) 1999-02-16
GB9501071D0 (en) 1995-03-08
PL184091B1 (pl) 2002-08-30
NO308843B1 (no) 2000-11-06
EP0804417A1 (en) 1997-11-05
ATE242214T1 (de) 2003-06-15
CA2208522A1 (en) 1996-07-25
FI973040A (fi) 1997-07-17
PL321378A1 (en) 1997-12-08
KR19980701432A (ko) 1998-05-15
DK0804417T3 (da) 2003-10-06
MX9705428A (es) 1997-11-29
CA2208522C (en) 2007-03-13
DE69628540D1 (de) 2003-07-10
KR100404390B1 (ko) 2004-01-31
PT804417E (pt) 2003-09-30
HUP9901418A3 (en) 2001-01-29
JP4015696B2 (ja) 2007-11-28
WO1996022281A1 (en) 1996-07-25
CN1168134A (zh) 1997-12-17
NO973312L (no) 1997-07-17
FI117437B (fi) 2006-10-13
FI973040A0 (fi) 1997-07-17
HU227426B1 (en) 2011-05-30
BR9606821A (pt) 1997-12-23
CN1172912C (zh) 2004-10-27
EP0804417B1 (en) 2003-06-04
DE69628540T2 (de) 2004-01-08
HUP9901418A2 (hu) 1999-08-30

Similar Documents

Publication Publication Date Title
NO973312L (no) Racemiseringsprosess for fremstilling av Levobupivacaine og beslektede piperidinkarboksanilid-bedövelsesmidler
DE69637726D1 (de) Gruppen zum einfangen von nukleinsäuren
DE69629670D1 (de) Lactam-enthaltende hydroxamsäure-derivate, deren herstellung und deren verwendung als inhibitoren von matrix-metalloproteasen
AU3738597A (en) Molecular model for vla-4 inhibitors
NO314725B1 (no) N-substituerte indol-3-glyoksylamider, deres fremstilling, anvendelse for fremstilling av medikamenter, legemidler inneholdende disse samt enfremgangsmåtefor fremstilling av et legemiddel
DE69535592D1 (de) Verbesserung der effektivität von arzneimitteln duren deuterierung
UA32566C2 (uk) Спосіб одержання штаму мікроорганізму, спосіб продукування триптофану
DE69942068D1 (de) Erzeugen eines nichtlinearen modells und erzeugen tzung desselben
FI980862A (fi) Kiraalisia metyylifenyylioksatsolidinoneja
DE69531624D1 (de) Verfahren zur herstellung von levobupivacaine und analoge
TR199800011T1 (xx) Benzo$g] kuinolin t�revleri
BR9809389A (pt) Tratamento de distúrbios do sistema nervoso central com modulados de receptores de estrogênio seletivos
NO982712D0 (no) FremgangsmÕter og mellomprodukter for fremstilling av 1-benzyl-4-((5,6-dimetoksy-1-indanon)-2-yl)metylpiperidin
IS4244A (is) Aðferð til framleiðslu á Indoline afleiðum og notkun þeirra
DE69525950D1 (de) Racemisierungsverfahren bei der herstellung von levobupivacaine und analogen
DE69710051D1 (de) Auflösungsverfahren von threo-methylphenidate
NO981444L (no) Akustisk transduser, hydrofon med slik transduser og fremgangsmÕte for fremstilling av hydrofoner
DE59604829D1 (de) Kontinuierliches Verfahren zur Herstellung von 4-Amino-2,2,6,6-tetramethylpiperidin
NO304828B1 (no) Nye cykliske aminosyrer og derivater derav, fremgangsmÕte til deres fremstilling samt mellomprodukt
DK0914605T3 (da) Molekylemodel for VLA-4-inhibitorer
NO20023386D0 (no) Pseudopolymorf av (-)-cis-2-(2-klorfenyl)-5,7-dihydroksy-8(4R- (3S-hydroksy-1-metyl)piperidinyl)-4H-1-benzopyran-4-on
ATE212969T1 (de) Verfahren zur herstellung von 2-halogenindan-1- onen
DE3673744D1 (de) Dihydropyridinderivat, verfahren zu seiner herstellung und dieses enthaltende pharmazeutische zusammensetzung.
DE69627184D1 (de) 3-aminoethyl-n-amidino-2,5-dihydropyrrol derivative mit arginine-mimetischen eigenschaften
AU7377296A (en) Method for treating hepatitis virus infection

Legal Events

Date Code Title Description
MK1K Patent expired